Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





Income Statement
Balance Sheet
Cash Flow Statement

Common Size IS
Op Efficiency
Credit Analysis

Immune Therapeutics, Inc. (IMUN)

Income Statement

Standardized | As Reported Annual | Quarterly | TTM
  Older >>
In millions, except per share itemsJun-30-23Sep-30-22Jun-30-22Mar-31-22Dec-31-21Sep-30-21Jun-30-21Mar-31-21
   10-Q10-Q10-Q10-Q10-K10-Q10-Q10-Q
Revenues   0.0-3.0-2.7-2.7-2.70.30.0
            Revenue growth   -100.0%-1103.4%-5079877.4%581.1%581.1%-175.4%-100.0%
Cost of goods sold   0.00.00.00.00.00.00.0
Gross profit   0.0-3.0-2.7-2.7-2.70.30.0
            Gross margin   0.0%100.0%100.0%100.0%100.0%100.0%0.0%
Selling, general and administrative   [+] 1.00.70.60.60.70.70.5
Research and development        0.30.2
Other operating expenses     -0.90.30.30.2 
EBIT   [+] 0.1-2.7-2.5-3.7-3.9-0.8-0.8
            EBIT margin   62606.0%89.4%91.4%139.1%146.0%-282.4%-1470088.7%
Non-recurring items   [+]   -1.8-3.0-3.00.1 
Interest expense   0.20.20.20.20.30.40.5
Other income (expense), net   [+] -2.33.11.14.54.15.24.4
Pre-tax income   -3.52.10.23.62.93.93.2
Income taxes   0.00.00.00.00.00.00.0
            Tax rate   0.0%0.0%0.0%0.0%0.0%0.0%0.0%
Net income   -3.52.10.23.62.93.93.2
            Net margin   -1730881.5%-71.7%-8.9%-133.2%-107.0%1296.2%5984705.7%
   
Basic EPS   [+] ($0.22)$4.00$0.49$7.44$6.05$8.22$6.84
Diluted EPS   [+] ($0.18)$0.28$0.04$0.36$0.25$0.46$0.38
   
Shares outstanding (basic)   [+] 15.40.50.50.50.50.50.5
Shares outstanding (diluted)   [+] 19.47.75.89.911.58.48.4
   
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.  

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy